Fertility Cryopreservation by Francesca Ciani et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
16 
Fertility Cryopreservation 
Francesca Ciani1, Natascia Cocchia2, Luigi Esposito3 and Luigi Avallone1 
1Department of Biological Structures, Functions and Technology 
2Department of Veterinarian Clinical Sciences 
3Department of Animal Sciences and Inspection of Food of Animal Origin  
University of Naples Federico II 
Italy 
1. Introduction 
The cryobiology is the science of low temperature biology. Fertility cryopreservation is a 
vital branch of reproductive science and involves the preservation of gametes (sperm and 
oocytes), embryos, and reproductive tissues (ovarian and testicular tissues) for use in 
assisted reproduction techniques (ART). The cryopreservation of reproductive cells is the 
process of freezing, storage, and thawing of spermatozoa or oocytes. It involves an initial 
exposure to cryoprotectants, cooling to subzero temperature, storage, thawing, and finally, 
dilution and removal of the cryoprotectants, when used, with a return to a physiological 
environment that will allow subsequent development. Proper management of the osmotic 
pressure to avoid damage due to intracellular ice formation is crucial for successful freezing 
and thawing procedure. 
Management of non-cryopreserved reproductive cells (i.e., spermatozoa or oocytes) and 
tissues (i.e., testicular tissue or ovarian tissue) is problematic due to difficulties in donor-
recipient synchronization and the potential for transmission of infectious pathogens, which 
cumulatively limits widespread application of these techniques. Cryopreserved cells and 
tissues can endure storage for centuries with almost no change in functionality or genetic 
information, making this storage a method highly attractive. Cryopreservation procedures 
are established on the basis of cellular physical characteristics in order to maintain viability 
and limit membrane damage that may occur during exposure to such non-physiological 
conditions as sub-zero temperatures, ice format, ion and high solute concentrations. 
Afterwards, there is a pressing need for the development of optimum cryopreservation 
methods for reproductive cells and tissues from many species. There are two major 
techniques for cryopreservation: freeze-thaw processes and vitrification. The major 
difference between them is the total avoidance of ice formation in vitrification. However, the 
biotechnology of the reproduction, although widely implemented, has generated protocols 
currently used to cryopreserve bovine sperm or oocytes, for example, that are still 
suboptimal, and cannot readily be extrapolated to other species' gametes.  
ART provide an ensemble of strategies for preserving fertility in patients and 
commercially valuable or endangered species. Nevertheless, it is very difficult to 
successfully cryopreserve. Currently, there is a growing interest to understand the 
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underlying cryobiological fundamentals responsible for low survival rates in an effort to 
develop better cryopreservation. 
The key factors that affect the life-span of spermatozoa are the combinations of storage 
temperature, cooling rate, chemical composition of the extender, cryoprotectant 
concentration, reactive oxygen species (ROS), seminal plasma composition and hygienic 
control. Sperm preservation protocols vary among animal species owing to their inherent 
particularities that change extenders used for refrigeration and freezing. 
On the other hand, oocytes are available only in limited number as compared to 
spermatozoa, therefore, a cryopreservation protocol must allow a high rate of viability 
maintenance when they are employed in practical application in ART programs. One of the 
key factors that influence the freezing process is the ratio of surface area to volume. The 
oocytes require a longer time to reach osmotic balance with the cryoprotectant solution than 
the spermatozoa, due to their bigger volume. Then, during cooling of oocytes, various forms 
of cellular damage may occur, including cytoskeleton disorganization, chromosome and 
DNA abnormalities, spindle disintegration, plasma membrane disruption and premature 
cortical granule exocytosis with its related hardening of the zona pellucida. 
Currently, there is an increasing research effort directed towards the utilization of 
cryopreserved testicular tissue containing abundant numbers of germ cells at various 
developmental stages. Advanced stage (i.e., spermatids, spermatozoa) germ cells can be 
successfully retrieved from cryopreserved testicular tissue following mechanical extraction 
or enzymatic digestion, and it is now possible to harvest these cells at earlier stages of 
development (i.e., spermatogonia) for further maturation in vivo. 
The ovarian cortex contains many thousands of primordial follicles composed of early stage 
oocytes surrounded by a single layer of granulosa cells. These cells may be less sensitive to 
cryopreservation damage because they are small and without a zona pellucida. Therefore, 
animal gametes have been shown to survive storage at low temperatures, and recent results 
are very encouraging, although reproducible methods have yet to be obtained in many 
species.  
2. History 
The idea of cryopreserving human sperm dates back to 1776, when Lazaro Spallanzani, 
member of the italian clergy and scientist reported that sperm became motionless when 
cooled by snow. In 1866, Mantegazza was the first to suggest posthumous reproduction for 
soldiers about to die in combat by shipping their frozen sperm back home.  
The technology behind reproductive cell and tissue cryopreservation has been derived from 
basic scientific principles, developed over the last 50 years. The use of theoretical techniques 
combined with experimental research has led to many exciting improvements and provided 
insight into optimal methods of cryopreservation. The fertility cryopreservation has been an 
ever increasing field since Polge et al., (1949), in United Kingdom, produced the first chicks 
from cryopreserved fowl sperm, in which, partly by error, a sample was frozen with 
additional glycerol. Afterwards, Bunge & Sherman (1953) found that human spermatozoa 
treated with 10% glycerol and freezed with 'dry ice' survived in high precentage. Edwards et 
al. (1969) fertilized the first human egg in vitro. In the subsequent decades, assisted fertility 
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clinics and commercial animal breeders have been using cryopreserved sperm successfully 
for artificial insemination. Although it had been shown that sperm could survive freezing 
and storage at low as -196° C, the functional ability of previously frozen sperm did not 
become apparent until the introduction of cryoprotectants. Sherman (1964) was the first to 
demonstrate the functional capacity of previously frozen sperm to fertilize an oocyte. The 
first successful human pregnancy as a result of frozen sperm was in 1969 and following this, 
the freezing of human sperm was largely done until the first sperm bank was opened in 
California in 1977. The birth of the first child to in vitro fertilization heralded the onset of a 
global expansion in the use of ART to treat infertile couples. This renewed the interest in 
cryobiological technology in an effort to preserve surplus embryo for future use (Kelly et al., 
2003). Afterwards, methods of fertility recovery widened from sperm cryopreservation to 
oocytes and embryo cryopreservation. 
3. Cryobiology fundaments 
Cryopreservation holds tissues at temperature between -140 and -200° C, at this range no 
biological activity can occur, producing a state of “suspended animation” of tissue that can 
be maintained indefinitively (Fuller & Paynter, 2004). Cryopreserved cells and tissues can 
endure storage for centuries with almost no change in functionality or genetic information, 
making this storage a method highly attractive. Cryopreservation is the process of cooling 
and warming, cryo-storage that harms cells or tissue (Mullen & Critser, 2007; Barrett & 
Woodruff, 2010). 
Freezing is the separation of pure water as ice, which concentrates any solutes present in the 
remaining liquid phase. This raises the possibility of two sources of freezing injury, ice itself 
and the altered liquid phase. Water is everywhere in the cell, it is important for the functions 
of the macromolecules and other cell structures such as lipid membranes. It is the universal 
biocompatible solvent, but also possesses unique properties for stability of living cells. Low 
temperatures have defined effects on cell structure and function and it is the phase 
transition of water to ice that is the most profound challenge for survival (Fuller & Painter, 
2004). Some effects of cooling are frankly harmful: for example, cooling switches off the Na-
pump, which is responsible for the regulation of cell volume, and as a result cooled cells 
swell (Leaf, 1959); membrane lipids undergo phase changes which may in themselves be 
harmful, and which also have dramatic effects on the reaction rates of membrane-bound 
enzymes (Lyons, 1972); poorly soluble materials may precipitate, and dissociation constants 
change, resulting in changes in the composition and pH of solutions (van den Berg, 1959; 
van den Berg and Rose, 1959); some cells are damaged or even killed by a reduction in 
temperature per se, especially if cooling is rapid, a phenomenon known as thermal shock 
(Lovelock, 1955). 
An implicit assumption is that the conditions leading to the formation of large ice crystals 
inside the cell is lethal (Mazur, 1977), then to preserve structurally intact living cells and 
tissue, the techniques of cryopreservation focus attention on the mechanisms of damage and 
protection in living cells and tissues at low temperatures in attempts to preserve the viability 
of tissues (Muldrew & McGann, 1990). Several approaches are being taken to understand 
and avoid potential damaging conditions during cooling by reducing the total amount of ice 
formed (Farrant et al., 1977), or by preventing the formation of ice (Mazur, 1963).  
www.intechopen.com
 Advances in Embryo Transfer 
 
228 
The formation of ice in the environment of the cell induces changes to which the cell must 
respond. The morphology of ice crystals formed during freezing depends on many factors, 
including the composition of solution, the cooling rate, and the temperature. When a cell 
suspension is cooled below its freezing point, water is removed from the isotonic solution in 
the form of ice, increasing the concentration of solutes (e.g., salt), which remain in the 
unfrozen fraction and hence increasing the osmotic pressure of the remaining unfrozen 
solution which not only helps to reduce ice formation inside the cell but also severely 
dehydrates cells and can cause cell damage and death. The isotonic salt solution (0.15 M) is 
cooled at -0.56° C. As the cooling is continued, and further ice separates, the salt, in the 
remaining liquid, is more concentrated. The remaining solution is progressively diminished 
in volume and increased in strength until at -21.1° C the saline has reached a concentration 
of 5.3 M; at this temperature, eutetic point, the remaining solution solidifies. Therefore, 
when cells are suspended in isotonic saline that is frozen, they are subjected to a 32-fold 
increase in sodium chloride concentration. In the mixed solute systems that occur in 
practice, similar changes in osmolality occur, but in addition there are changes in 
composition brought about by differing solubility characteristics of the various solutes 
(Pegg, 1976; 2007). The dynamics of cell volume change are important in relation to possible 
membrane damage by mechanical means such as plasma membrane stretching and even 
rupture (Leibo et al., 1978; Mazur & Schneider, 1986).  
The formation of ice is normally entirely extracellular. There are several reasons for this. In 
the first place, when heat is removed by conduction from the external surface of the 
specimen, the coldest point will always be in the extracellular fluid. Secondly, the 
extracellular fluid forms one large compartment, whereas the intracellular space consists of 
very many small compartments: the probability of ice nucleation occurring in any given 
compartment is directly related to its size, and this makes it inevitable that nucleation will 
occur in the extracellular fluid before a significant number of cells have frozen internally. 
Once ice has started to form, it will propagate throughout that compartment until 
equilibrium is reached. Hence, even if a few cells should freeze internally before 
extracellular freezing starts, once extracellular ice has formed it will continue to grow in that 
space, and since cell membranes are impermeable to the main solutes present, water will be 
withdrawn from the cells by the increased external osmolality. Hence the cells will shrink, 
and so long as cooling is slow enough to allow water to leave the cells to maintain 
equilibrium, no further intracellular freezing will occur. Thus, it is important to understand 
how cooling can be used to produce stable conditions that preserve life.  
Although many cells and tissues can be successfully cryopreserved, without intracellular ice 
formation, and can be stored in liquid nitrogen indefinitely, there could be the risk of ice 
formation during the thawing process, if conducted improperly. If samples are thawing 
slowly, ice crystals can form and/or grow causing more damage; however, if samples are 
thawed rapidly enough, there is little time for ice nucleation and growth to occur (Fabbri, 
2006; Fabbri et al., 2006). 
The phenomenon of recrystallization in frozen samples occurs as smaller ice crystals with 
higher surface energy dissolve and larger crystals grow; the rate of recrystallization 
increases with increasing temperature (Mazur & Schmidt, 1968). Recrystallization of both 
intracellular and extracellular ice occurs during warming although the total amount of ice 
decreases as the temperature increases. It has been suggested that cells cooled under 
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conditions resulting in little intracellular ice formation may be recovered undamaged if the 
warming rate is rapid, but would be irreparably damaged by the recrystallization of the 
intracellular ice on slow warming. This suggests that membrane damage caused by the 
osmotic pressure gradient may be resealed if the warming conditions prevent the 
recrystallization of ice crystals traversing the membrane (Mazur et al., 1972; McGann & 
Farrant, 1976). A similar resealing repair mechanism for freeze-thaw damaged cells was 
proposed by Law et al. (1980) which could also explain the 6% of cells that retained their 
barrier properties after forming intracellular ice. After thawing, there is further risk of damage 
during the course of removing cryoprotectants. If cells are immediately put into a significantly 
lower concentration of cryoprotectant, water will rapidly move into the cell and the cells can 
swell and burst. Therefore, it is usually advised that a series of decreasing concentrations of 
cryoprotectant is used to slowly remove the cryoprotectants and gently rehydrate cells. As an 
alternative, it can also be very effective to use a non-penetrating cryoprotectant such as sucrose 
to reduce osmotic shock during the step-down process (Shaw, 2000). 
4. Cryopreservation methods 
Two are the most utilized methods for gamete cryopreservation: slow freezing and 
vitrification. Slow freezing uses low concentrations of cryoprotectants which are associated 
with chemical toxicity and osmotic shock. Vitrification is a rapid method that decreases cold 
shock, without the risks of solution effects or crystallization, and uses high cooling rates in 
combination with a high concentration of cryoprotectant (Arav et al., 2002). 
4.1 Slow freezing 
Slow freezing is a conventional cryopreservation process in which a relatively low 
concentratiton of cryoprotectant is used (1.5 M), it shows little toxicity to cells or tissue and 
requires expensive equipment. As the cryoprotectant is added to cells, it results in initial 
cellular dehydration followed by a return to isotonic volume with the permeation of 
cryoprotctant and water. Generally, cells are cooled slowly using a controlled rate freezing 
machine, which allows samples to be cooled at various rates; ovarian tissue is generally 
cryopreserved at 2° C/min prior to ice seeding and 0.3° C/min after crystallization to ensure 
the tissue is dehydrated before intracellular ice formation occurs. Optimal rates to minimize 
intracellular rates formation vary among cells and tissue types (Fuller & Painter, 2007).  
It is generally believed that cell injury at low cooling rates is principally due to the 
concentration of both intracellular and extracellular electrolytes and that cryoprotectants act 
by reducing this build-up. Experimental data support this explanation, in fact the extent of 
damage to human red blood cells during freezing in solutions of sodium 
chloride/glycerol/water can be quantitatively accounted for by the increase in solute 
concentration. Furthermore, a given degree of damage occurs at lower concentrations of 
solute in the presence of higher concentrations of glycerol; it appears that glycerol 
contributes as element of damage itself (Barbas & Mascarenhas, 2009). 
4.2 Vitrification 
Whereas in conventional cryopreservation the concentration of the cryoprotectant is low 
and the cooling rate is very slow to avoid ice crystallization, vitrification is an ultrarapid 
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cooling technique that requires a high concentration of cryoprotectant. In 1985, vitrification 
was first reported with mouse embryos (Rall & Fahy, 1985) and was then further developed 
in animal reproduction (Ali & Shelton, 1993). In 1999 the first successful pregnancies and 
deliveries after vitrification of human oocytes were reported (Kuleshova et al., 1999). Since 
then, scientific interest on vitrification has risen significantly (Liebermann et al., 2002; 2003). 
The physical definition of vitrification is the solidification of a solution at low temperature, 
not by ice crystallization but by extreme elevation in viscosity during cooling, such that the 
cells or the tissues are placed into the cryoprotectant and then plunged directly into liquid 
nitrogen. Water is largely replaced by the cryoprotectant. The cooling rate achieved is 
between 15.000 to 30.000 C/min, and water is transformed directly from the liquid phase to 
a glassy, vitrified state. With this method no ice crystals form that can damage the cells or 
the tissues. This approach is attractive from a technical standpoint; unfortunately, 
cyroprotectant solutions are toxic to cells at very high concentrations. Solute toxicity is a 
major drawback of using vitrification for preservation, even with high cooling rates. To 
reduce toxicity, concentrations of cryoprotectants can be lowered as long as cooling is fast 
enough to preclude ice formation (Herrero et al., 2011).  
5. Cryoprotectants 
Intracellular freezing is generally lethal but can be avoided by sufficiently slow cooling, and 
under usual conditions solute damage dominates. However, extracellular ice plays a major 
role in cells and tissues. Cryoprotectants are defined functionally as any compound that 
increases cell survivability when used in a cryopreservation method and act primarily by 
reducing the amount of ice that is formed at any given subzero temperature. If sufficient 
cryoprotectant could be introduced, freezing would be avoided altogether and a glassy or 
vitreous state could be produced, but osmotic and toxic damage caused by the high 
concentrations of cryoprotectant that are required then become critical problems. The 
transport of cryoprotectants into and out of cells and tissues is sufficiently well understood 
to make optimization by calculation a practical possibility but direct experiment remains 
crucial to the development of other aspects of the cryopreservation process.  
Cryoprotectants are included in cryopreservation medium to reduce the physical and 
chemical stresses derived from cooling, freezing and thawing of sperm cells (Gao et al., 1997; 
Purdy, 2006). Cryoprotectants are classified as either penetrating or non penetrating. 
Penetrating cryoprotectants (glycerol, dimethyl sulfoxide, ethylene glycol, propylene glycol) 
cause membrane lipid and protein rearrangement, resulting in increased membrane fluidity, 
greater dehydration at lower temperatures, reduced intracellular ice formation, and 
increased survival to cryopreservation (Holt, 2000). Additionally, penetrating 
cryoprotectants are solvents that dissolve sugars and salts in the cryopreservation medium 
(Purdy, 2006). A non penetrating cryoprotectant (egg yolk, nonfat skimmed milk, trehalose, 
aminoacids, dextrans, sucrose) doesn’t cross plasma membrane and only acts extracellularly 
(Aisen et al. 2000). Therefore, non penetrating cryoprotectant may alter the plasma 
membrane, or act as a solute, lowering the freezing temperature of the medium and 
decreasing the extracellular ice formation (Amann, 1999; Kundu et al. 2002). 
The historic discovery of the cryoprotective effect of glycerol was made in 1948 when Polge 
et al. (1949) found that fowl spermatozoa had been cooled to -76° C in 1.1 M glycerol 
recovered with little damage after thawing. Many commonly used cryoprotective agents 
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penetrate cell membranes actually produces some problems and is certainly not a necessary 
property for cryoprotection. Penetrating cryoprotective agents like glycerol and 
dimethylsulphoxide (DMSO) permeate a good deal more slowly than water and 
consequently they all produce osmotic transients, the severity and duration of which vary 
with the compound and the cell in question. In general, osmotic disturbances have more 
severe effects during thawing and resuspension of the cells in cryoprotectant-free medium 
(when the solute is leaving the cells) than during initial equilibration and cooling (when it is 
entering the cells). This is due to the greater sensitivity of cells to swelling than to shrinkage. 
It is certainly very important to minimize osmotic disturbances during thawing and 
subsequent manipulations since they can contribute very significantly to the damage 
suffered by stored cells and tissues. 
The most used cryoprotectant for sperm is glycerol. Similar to nonpermeating 
cryoprotectants, glycerol exerts an extracellular effect by osmotic stimulation of cell 
dehydration, thus decreasing the volume of intracellular water available for freezing. An 
intracellular effect of glycerol, exerted through its ability to permeate the cell membrane, is a 
decrease of intracellular osmotic stress effect of dehydration. This occurs by replacing 
intracellular water necessary for the maintenance of cellular volume, interaction with ions 
and macromolecules, and depressing the freezing point of water. Permeating 
cryoprotectants, depending on the concentration used, are toxic and can induce membrane 
damage and decrease sperm motility. Important cellular features for determining the most 
appropriate freezing rates as well as types and concentrations of cryoprotectant used are 
surface to volume ratio, membrane permeability to water, and cryoprotectants (and the 
corresponding activation temperatures) and membrane liability to physical stress. 
Spermatozoa from different species require different protocols for successful 
cryopreservation because of inherited particularities in cell shape, cell volume, organelles 
size, and composition (Medeiros et al., 2002).  
Currently, three are the widely used permeating cryoprotectants in fertility 
cryopreservation: dimethyl sulfoxide (DMSO), ethylene glycol (EG), and propylene glycol 
(PG). These cryoprotectants have similar properties: solubility in water at low temperatures, 
cell permeability, and relatively low toxicity. However, each of these CPAs also has different 
degrees of membrane permeability, as has been shown with mammalian oocytes. 
The transport of cryoprotectants into and out of cells and tissues is sufficiently well 
understood to make optimization by calculation a practical possibility but direct experiment 
remains crucial to the development of other aspects of the cryopreservation process. 
6. Germplasm cryopreservation 
6.1 Why cryopreserve genetic material? 
Assisted reproductive technologies (ART) provide an ensemble of strategies for 
preserving fertility in patients and commercially valuable or endangered species. 
Cryopreservation is a way of preserving germplasm that have applications in agriculture, 
aquaculture, biotechnology and conservation of threatened species (Holt, 1997; Andrabi & 
Maxwell, 2007). 
Fertility cryopreservation is an emerging field that encompasses a variety of fertility 
therapies for patients anticipating medical treatment that could affect future reproductive 
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outcomes. Although most frequently associated with cancer treatment, fertility preservation 
has also been used for medical conditions like lupus, glomerulonephritis, and 
myelodysplasia, as well as in adolescent females with conditions known to be associated 
with premature ovarian failure (Jensen et al., 2011). 
Current indications for sperm storage are quite broad and include every case and circumstance 
in which a future damage to the male reproductive system is suspected. It is known that sperm 
cryopreservation mainly affects its motility (Donnelly et al., 2001). The indications for 
spermcryobanking have been greatly expanded since oocytes can be fertilized even by one 
viable spermatozoon through intracytoplasmic sperm injection (ICSI) (Palermo et al., 1992). 
Although intrauterine insemination with thawed sperm is less successful that with fresh 
sperm (Sherman, 1973), ICSI with thawed sperm is successful as long as viable spermatozoa 
are injected (Kuczynski et al., 2001). This procedure has enabled men who have few surviving 
seminal or even testicular spermatozoa to fertilize their partner’s oocytes. ICSI provides a 
realistic chance to achieve pregnancies and births when the sperm quantity and quality is 
extremely low, and in cases in which the sperm source is not renewable. 
Concerning threatened species, cryopreservation of genetic material is used to the genetic 
management programmes of those species and genetic resource banking (Holt, 1997). Semen 
banks are currently more developed for rare domestic breeds (cattle, sheep, goats and pigs) 
than for non-domestic species, but the concept of using them to facilitate the management 
and conservation of endangered species is being promoted extensively (Roth et al., 1997). In 
order to maximize genetic diversity, a rare animal from the family bovidae could be saved 
with 1000 sperm doses collected from 25 different males (Comizzoli et al., 2000).  
Nowadays, semen cryopreservation has other biotechnological applications. It can also be 
used to solve problems of preservation of semen and DNA from endangered species and, 
therefore, conservation of biodiversity. Cryopreservation of gametes is an important tool in 
assisted reproduction programmes; long-term storage of oocytes or spermatozoa is necessary 
when in vitro fertilization (IVF) or artificial insemination is to be performed at a future date or 
when geographical or temporal distance between donors result in non-simultaneous 
availability of male and female gametes, conservation by cryopreservation is the only option 
(Luvoni & Pellizzari, 2000). Cryopreservation of spermatozoa, oocytes, and embryo offer a 
potential tool for rescuing genetic material from alive or dead males or females of endangered 
populations, both if they are (Ciani et al., 2008; Cocchia et al., 2009; 2010). 
Cryopreservation of testicular tissue would benefit at least two groups of patients: 
prepubertal boys who are undergoing chemotherapy or radiotherapy and infertile men 
who are undergoing testicular biopsy. In spite of attempts to protect seminiferous 
epithelium by hormone treatments (Meistrich et al., 1996; Thomson et al., 2002), 
prepubertal boys often lose their sperm production during cancer treatment. Especially in 
connection with bone marrow transplantation, the destruction of spermatogonia is often 
inevitable, and also the Leydig cells probably undergo damage (Siimes & Rautonen, 1990). 
In postpubertal boys and men, cryopreservation of semen is clinically well established 
and widely used, but also in them, restoration of natural fertility after cancer treatment 
would be a great benefit (Song et al., 2010). 
Management of non-cryopreserved reproductive cells (i.e., spermatozoa or oocytes) and 
tissues (i.e., testicular tissue or ovarian tissue) is problematic due to difficulties in donor–
www.intechopen.com
 Fertility Cryopreservation 
 
233 
recipient synchronization and the potential for transmission of infectious pathogens, which 
cumulatively limits widespread application of these techniques (Woods et al., 2004). 
Paralleling the introduction of cryobiology to assisted reproduction has been the realization 
of a number of moral and ethical issues to gamete and/or embryo storage (Kelly et al., 2003). 
6.2 Sperm cryopreservation 
The most broadly practiced mammalian spermatozoa cryopreservation methods consist of a 
series of non-physiological steps that involve hypertonic cryoprotectant addition, cooling, 
warming, and cryoprotectant removal. Several studies have focused on the fundamental 
biophysical conditions that determine optimal cryoprotectant addition and removal, and 
cooling and warming rates (Morris et al., 1999). With this type of approach, it becomes 
theoretically possible to calculate the minimal number of cryoprotectanct. Sperm 
cryopreservation has been most successfully associated with human and bovine reproductive 
technologies. The most successful cryopreservation methods for spermatozoa from these 
species use slow initial cooling rates (1-5° C/min) starting from room temperature to a seeding 
temperature, followed by faster cooling rates after initial ice formation (100-200° C/min) in the 
presence of glycerol buffered with egg yolk-citrate medium.  
Mammalian sperm are very sensitive to cooling from body temperature to near the freezing 
point of water. Damage to sperm, known as cold shock, is observed as an irreversible loss of 
motility upon rewarming. Cold shock effects on other cellular functions, such as loss of 
selectivity in membrane permeability, can be observed as intracellular staining with dyes 
that are not permeable to the intact plasma membrane. Ultrastructurally, cold shock is 
manifested most clearly by a disruption of the acrosomal membranes. 
Membrane permeability is increased after cooling and this may be a consequence of 
increased membrane leakiness of specific protein channels. Calcium regulation is affected by 
cooling and this has severe consequences in cell function, inclusively cell death. The uptake 
of calcium during cooling influences capacitation changes and fusion events between 
plasma membrane and acrosomal membrane. Sperm membrane is a structure that 
undergoes reorganization during capacitation, and cryopreservation results in sperm being 
more reactive to their environment (Bailey et al., 2000). Cold shock reduces membrane 
permeability to water and solutes and injures acrosomal membranes (Purdy, 2006). The 
main changes that occurs during freezing are mainly ultrastructural, biochemical and 
functional, which impairs sperm transport and survival in the female reproductive tract and 
reduces fertility in domestic species (Salamon & Maxwell, 2006). The ultra structural 
damage is greater in ram than bull spermatozoa. Greater damages have been detected in 
plasma and acrosome membranes, mitochondrial sheath and axoneme (Salamon & Maxwell, 
2006; Barbas & Mascarenhas, 2009). 
There are only few studies dealing with sperm vitrification. Classical vitrification technique 
with high concentration of permeable cryoprotectants (30 to 50%) cannot be performed to 
cryopreserve human spermatozoa because of the lethal effect of osmotic shock. This is why 
vitrification had been performed mostly with oocytes and embryos. An alternative could be 
to use very rapid cooling and warming rates on a very small sample size. It has been shown 
that vitrification of human spermatozoa using cryoloops without cryoprotectants is possible 
Nawroth et al., 2005). Furthermore, why can vitrification be successful in the absence of 
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cryoprotectants? Probably it depends on the size and the more stability of human 
spermatozoa respect to other mammals (boar, bull, ram, rabbit, cat, dog, and horse). 
Furthermore, the amount of osmotically inactive water is higher in spermatozoa, and is 
bound to several macromolecular structures such as DNA, histones, hyaluronidase, etc. 
(Thurston et al., 2002). Therefore, the amount of high molecular weight components can be 
6–16 times higher than in embryos, resulting in enhanced viscosity and glass transition 
temperature The DNA integrity of vitrified sperm is comparable with that of slowly 
frozen/thawed spermatozoa. Such findings suggest that a wide range of cooling rates for 
spermatozoa can be acceptable (Isachenko et al., 2003; 2004a; 2004b; Nawroth et al., 2005).  
Cryopreservation of testicular tissue is offered in some centres but is still considered 
experimental; potential future uses include in vitro maturation of spermatogonia into 
spermatocytes or germ-cell transplant into native testicular tissue. 
7. Female germplasm cryopreservation 
7.1 Introduction 
During the course of the last 55 years, the science of reproductive biology, namely in vitro 
fertilization (IVF), has coincided with the ability to preserve embryos and oocytes (Fuller & 
Paynter, 2004). Currently, embryo and oocyte cryopreservation is the sole approved 
technology for human female patients wanting to preserve genetic material for future use.  
Preservation of female genetics can be done through the preservation of germplasm (oocytes 
and embryos). It can also be done by preservation of ovarian tissue or entire ovary for 
transplantation, followed by oocyte harvesting or natural fertilization.  
For most of the species on Earth, with current knowledge in cryopreservation, probably only 
male gametes can be preserved, whereas oocytes or embryos at any stage of development 
cannot. The culprits are in the vast differences in size, composition, and associated 
structures. As such, the issue of intracellular ice formation becomes a major concern, even at 
relatively slow cooling rates.  
Embryo cryopreservation has been a proven method to preserve fertility. The first report on 
successful embryo cryopreservation was published in Whittingham (1977), Whittingham et 
al. (1972), Wilmut (1972) and Wilmut & Rowson (1973), more than two decades after Polge 
et al. (1949), that reported their success in freezing spermatozoa. The modification of cooling 
rate that came a few years later (Willadsen et al,. 1976; 1978) resulted in a basic protocol that 
is still in large use today. Thus, cryobanking of embryos can help in establishing founder 
populations with the aim of eventual reintroduction into the wild (Ptak et al,. 2002). 
However, evolution made each species unique in many aspects, one of which is the 
development of highly specialized reproductive adaptation, a specialization that is part of 
the definition of a species. While thousands and thousands of offspring were born following 
the transfer of frozen–thawed embryos in humans, cattle, sheep, and mice, success is very 
limited in many other, even closely, related species (Abe et al., 2011; Aller et al., 2002). 
To date, the number of species in which embryo cryopreservation has been reported 
stands only at about 40 including humans and domestic and laboratory animals. In wild 
animals, especially with endangered species, this is often almost impossible, and the 
opportunity to collect oocytes or embryos is very rare. To overcome this limitation, 
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researchers find imperative to use laboratory, farm, or companion animals as models 
during the process of developing of the necessary reproductive techniques associated 
with embryo cryopreservation. In some instances, appropriate model species were found. 
For example, studies on the domestic cat helped to develop various technologies, which 
were later applied to nondomestic cats (Dresser et al. 1988; Pope et al., 1984; Pope, 2000; 
Cocchia et al., 2010) or cattle served as a model for other ungulates (Loskutoff et al., 1995). 
Unfortunately, for many species (e.g. elephant, rhinoceros), no suitable model can be 
located, and studies should be conducted with the limited available resources with 
relying on the already available knowledge from research on other species (Bilton & 
Moore, 1976; Breed et al., 1994). 
Cryopreservation of embryos in the few mammalian species in which it was attempted 
shows some, though often very limited, success. When considered from conservation 
standpoint, embryo freezing has the advantage of preserving the entire genetic 
complement of both parents, but it is not always possible to obtain embryos for the female 
valuable genetic material preservation. In many situations, then, oocyte and ovarian tissue 
cryopreservation represent an attractive potential means of preserving female germ cells 
for subsequent use in assisted reproduction (Vajta & Nagy, 2006; Abir et al., 2006; 
Whittingham & Adams, 1974). 
In Human Chemotherapy and/or radiotherapy can induce premature ovarian failure in 
most of female cancer patients. Some patients may be too sick or too young to undergo 
fertility treatments or have hormone sensitive cancers that preclude standard approaches. 
As current cancer treatments improve, the survival rate of young female cancer patients has 
steadily increased. However, ionizing radiation and most of alkylating agents (e.g., 
busulfan, carboplatin, chlorambucil, cisplatin, cyclophosphamide, dacarbazine, ifosfamide, 
thiotepa) that used for gonadotoxic chemotherapy regimens can often induce premature 
ovarian failure, rendering the patient infertile. In addition, bone marrow transplantation, 
which is used in the treatment of cancerous and noncancerous hematologic diseases, also 
results in ovarian failure because heavy chemotherapy and radiotherapy is utilized to 
destroy the pre-existing bone marrow. Also, in nearly all cancers, with the possible 
exception of breast cancer, chemotherapy is initiated soon after diagnosis. Because 
preparation and stimulation for oocyte retrieval usually requires 2 to 3 weeks or longer, it is 
generally not feasible to freeze embryos from an adult female cancer patient for potential 
future use. Even in breast cancer patients, most would not be candidates for oocyte or 
embryo freezing due to concerns that high estrogen levels might have detrimental effects on 
the primary tumor. Additionally, not all patients have partners with whom they can create 
embryos for cryopreservation. 
Therefore, most female cancer patients of reproductive age do not have the option of 
utilizing established assisted reproductive technologies to safeguard their fertility so far. 
For women facing upcoming cancer therapies, cryopreservation of ovarian tissue and 
oocytes is a technology that holds promise for banking reproductive potential for the future. 
Also, oocytes freezing offers future “social choice” in single woman, for ethical or religious 
problems or for governmental regulation. Non-human primates serve as research models 
for humans in a wide variety of fields, things work the other way around when it comes to 
female germplasm cryopreservation (Almondin et al., 2010; Cranfield et al., 1992). Industry 
www.intechopen.com
 Advances in Embryo Transfer 
 
236 
needs pushed frozen–thawed ET in the cattle industry to commercial levels (Abe & Hoshi, 
2003; Armstrong et al., 1995). According to a recent report by the International ET Society, 
over 300 000 frozen–thawed bovine embryos were transferred in 2008 worldwide. In this 
species, oocyte cryopreservation is very successful, and it has led to develop other correlates 
methods, such as superovulation techniques, and ovum pick up and In Vitro Embryo 
Production (IVEP) with no surgical methods.  
The domestic buffalo (Bubalus bubalis) is a multipurpose livestock species in many 
countries of the world, particularly in South Asia, the Mediterranean region of Europe and 
South America, and is an indispensable source of employment to the marginal farmers and 
landless labourers. Recent advances in reproductive techniques, including superovulation, 
ovum pick-up and cryopreservation of oocytes offer numerous possibilities for the wider 
exploitation and dissemination of superior buffalo genotypes. Although the horse was 
probably the first animal to experience and benefit from artificial insemination, it trailed the 
field somewhat with regard to the application of embryo transfer and other oocyte and 
embryo-related modern breeding technologies. 
In wild animals, especially with endangered species, it is very rare to collected the embryo 
but the collection of oocytes or ovary is possible, eventually also post mortem. For example 
the cryopreservation of female germoplasm is an important tool in assisted reproduction 
programs of feline species. Gamete cryopreservation represents an important tool for the 
development of efficient ART, and oocyte cryopreservation could facilitate the preservation 
of genetic resources in domestic and wild animals. It has been demonstrated that the 
domestic cat oocytes can serve as a successful recipient of nuclear transfer from related non-
domestic cats (Cocchia et al., 2010). 
Maintenance of biodiversity has intrinsic value for the genetic preservation of valuable 
domestic cat breeds and an extrinsic value for conservation management of taxonomically 
related non-domestic feline species (Luvoni, 2006). These observations are valid in different 
wild species as carnivore or ungulate. However, while live offspring have been produced 
using cryopreserved oocytes in a number of species: man (Chen, 1986); mouse, cattle, horse 
(Maclellan et al., 2002). The oocytes collection before cryopreservation or in vitro embryo 
production can be performed at different stage. The oocytes at a very early stage of 
maturation or immature (GV stage) can be collected from birth or sexually immature 
animals from ovary or ovarian tissue collected by surgery or post mortem. The mature 
oocytes (MII stage) can be collected from woman and mammalian after puberty by 
hormonal stimulation and non-surgery ovum pick-up. 
To be fertilized, an oocyte needs to reach the metaphase II (MII) stage of maturation, or 
otherwise the probability of fertilization is very low (Luvoni & Pellizzari 2000). Thus, an in 
vitro maturation (IVM) procedure should be in hand to handle immature oocytes, and this 
process is currently developed for only a handful of species and even for these success is 
often fairly limited (Krisher, 2004). Furthermore, collection of immature oocytes following 
chemical stimulation disrupts the natural maturation process and thus compromises the 
quality of oocytes even if they were later matured in vitro (Moor et al., 1998; Takagi et al., 
2001). During oocyte maturation and follicular growth, oocytes accumulate large quantities 
of mRNA and proteins needed for continuation of meiosis, fertilization, and embryonic 
development (Krisher, 2004). In the absence of the entire supporting system during IVC, 
production of some needed components is hampered resulting in suboptimal oocytes 
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(Krisher, 2004). Despite numerous studies on the issue, to date, no morphological or other 
method is able to accurately predict which oocytes have optimal developmental potential 
(Coticchio et al. 2004). Even so, it is clear that oocyte quality is a major determining factor in 
the success of IVF, early embryonic survival, establishment and maintenance of pregnancy, 
fetal development, and even adult disease (Coticchio et al. 2004, Krisher 2004; Wolf et al., 
1989). Once all these hurdles have been overcome and keeping in mind the importance of 
oocyte quality, the next major hurdle to overcome is oocyte cryopreservation (Allen, 2010). 
7.2 Oocyte cryopreservation 
7.2.1 Factors affecting oocyte freezing and resolution 
Oocytes are very different from sperm or embryos with respect to cryopreservation. The 
volume of the mammalian oocyte is in the range of three to four orders of magnitude larger 
than that of the spermatozoa, thus substantially decreasing the surface-to-volume ratio and 
making them very sensitive to chilling and highly susceptible to intracellular ice formation 
(Ruffing et al., 1993, Arav et al., 1996).  
This problem becomes even more pronounced in non-mammalian vertebrates (fish, birds, 
amphibians, and reptiles) whose oocytes are considerably larger than those of mammals 
(Guenther et al., 2006). Oocytes of amphibians, for example, are 20–25 times larger than 
human oocytes. Several parameters have been taken into account in oocyte 
cryopreservation: cell characteristics, permeability to the cryoprotectants, toxicity, 
temperature and time of exposure to the cryoprotectants. Chilling injury is the main obstacle 
to successful oocyte cryopreservation. It has been reported that chilling injury affects the 
membrane, the microtubule, the cytoskeletal organization and the zona pellucida. 
Chromosome abnormalities also were observed after cryopreservation of human and mouse 
oocytes. Most striking sample is the effects of freezing on the second meiotic spindle where 
microtubules are disrupted or disassembled because of tubulin depolimerization.  
Several approaches have been used to overcome the damage caused by chilling injury. 
Significant improvements have been obtained with rapid cooling throughout the transition 
phase, or by the addition of substance known to stabilize the plasma membrane against the 
thermal effect of oocytes: such as proteins (linoleic acid–albumin), sugar (sucrose or 
trehalose) anti-oxidant (Butylated Hydroxytoluene). In addition, supplementation of choline 
and higher sucrose concentration in the freezing solution can promote the retention of an 
intact chromosome segregation apparatus comparable in incidence to freshly collected 
oocytes (Willadsen et al., 1974). 
7.2.2 Effect of meiotic stage 
The meiotic stage seems to influence the survival of oocytes after freezing. Differing 
sensitivity to the cooling procedures for the oocyte cryopreservation has been related to the 
cell cycle stage during meiosis. The metaphase-II (MII) oocyte is extremely fragile due to its 
large size, water content, and chromosomal arrangement. In the mature oocyte, the 
metaphase chromosomes are lined up by the meiotic spindle along the equatorial plate. 
Increases in chromosomal aberrations in matured oocytes were observed upon cooling and 
cryopreservation due to the alteration to the meiotic spindle. MII oocytes are susceptible to 
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cryopreservation damage because of disruption of the metaphase spindle microtubule 
integrity during slow cooling, which may result in aneuploidy after fertilization of thawed 
oocytes. The plasma membrane of oocytes at the MII stage has a low permeability 
coefficient, thus making the movement of CPs and water slower (Ruffing et al., 1993). They 
are surrounded by zona pellucida, which acts as an additional barrier to movement of water 
and CPs into and out of the oocyte. As a result of the freeze–thaw process, premature 
cortical granule exocytosis may take place, leading to zona pellucida hardening and making 
sperm penetration and fertilization impossible (Mavrides & Morroll, 2005), a process that 
can be overcome by the use of ICSI or subzonal sperm insertion. Oocytes also have high 
cytoplasmic lipid content that increases chilling sensitivity (Ruffing et al., 1993). They have 
less submembranous actin microtubules making their membrane less robust. 
Cryopreservation can cause cytoskeleton disorganization, and chromosome and DNA 
abnormalities (Luvoni, 2006). The meiotic spindle, which has been formed by the MII stage, 
is very sensitive to chilling and may be compromised as well (Ciotti et al., 2009). It does, 
however, tend to recover to some extent after thawing or warming and IVC, recovery that is 
faster following vitrification than following slow freezing (Ciotti et al., 2009). Oocytes are 
also more susceptible to damaging effects of reactive oxygen species (Gupta et al., 2010). 
Despite many advances in the field of cryopreservation, specifically with regards to oocytes 
(ovulated, mature or immature), their cryopreservation is still not considered an established 
procedure and thus its current label as experimental technique (Noyes et al., 2010).  
An alternative to cryopreservation of mature oocyte is to freeze oocyte when they have 
reached full size and become meiotically competent, but before they resume maturation and 
proceed to MII. It has been showed that oocytes frozen at the germinal vesicle (GV) stage 
survive better than those frozen at the metaphase-II stage (Luvoni & Pellizzari, 2000). 
Additionally, oocytes frozen at the GV stage have lower rates of abnormalities in the 
resulting meiotic spindle than oocytes frozen at the MII stage. At this stage the oocyte does 
not present a chilling-sensitive microtubular or meiotic spindle. Several other reports, 
however, paradoxically showed that the immature oocytes are more sensitive to freezing 
than mature oocytes, probably due to lower cell membrane stability and a particular 
cytoskeletal formation. This sensitivity to cryopreservation also seems to be due to the 
damage or interruption of cumulus cell projections, which may control the intercellular 
communication between cumulus cells and oocytes during maturation. Even though GV 
oocytes have a superior thaw survival rate and a lower incidence of meiotic spindle damage, 
the continued inefficiency of in vitro maturation protocols results in a final yield of mature 
oocytes that is similar to that obtained with cryopreserved metaphase-II oocytes.  
Immature oocytes seem to be less prone to damages caused by the chilling (at the nuclear 
level), freezing, and thawing procedures, and they, too, can be cryopreserved by controlled-
rate freezing (Luvoni & Pellizzari, 2000) or vitrification (Arav et al., 1993). Preantral oocytes 
can be preserved inside the follicle, and about 10% seem to be physiologically active after 
thawing and 1 week of culture (Nayudu et al., 2003). However, culture conditions that allow 
these oocytes to grow and reach full maturation are still largely unknown despite attempts 
in several species. The only species in which live young were produced from fresh (Eppig & 
O’Brien, 1996) or frozen–thawed (Carroll et al., 1990) primary follicles is the mouse. Some 
very limited success was also reported in cats, where following vitrification in 40% EG, 3.7% 
of the in vitro matured oocytes were able to develop to the blastocyst stage following IVF 
(Murakami et al., 2004). 
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The problems associated with maturation of early-stage oocytes in vitro are the need to 
develop the complex endocrine system that supports the development at different stages, 
other culture conditions that will ensure survival (oxygen pressure for example) and, in 
many species, the duration of time required to keep the follicles in culture. Another option 
for isolated oocyte freezing is freezing individual primordial follicles and later transplanting 
them to the ovarian bursa, where they can mature and eventually produce young offspring 
following natural mating as was shown in mice. Alternatively, ovarian cortex tissue or the 
entire ovary can be frozen or vitrified and then, after thawing/warming, transplanted to 
allow maturation in vivo (Candy et al. 1995), or else the oocytes can be fertilized and the 
resulting embryos can then be cryopreserved. 
7.3 Female germplasm cryopreservation techniques 
Cryopreservation holds tissues at temperatures between –1400 and –2000C, at which no 
biological activity can occur, producing a state of “suspended animation” of tissues that can 
be maintained indefinitely. It is the process of cooling and warming, not long-term cryo-
storage, that harms cells or tissue. The success of these approaches depends upon the tissue, 
the cryoprotectant, and the freezing vessel used. 
In the intervening years, variation to oocytes cryopreservation methods including changes 
in sucrose and sodium concentration in slow freezing media, along with the first report of 
successful oocyte vitrification and the development of novel cryotools have combined to 
provide consistently improved survival and pregnancy rate for oocyte cryopreservation. 
Two basic techniques have currently been used in the field of female germplasm 
cryopreservation, that is, slow freezing technique (Whittingham, 1977, Whittingham et al., 
1972, Wilmut, 1972, Willadsen et al., 1976; 1978) and vitrification. Slow freezing method is 
a standard operating procedure in most IVF centers, but it is a time consuming procedure. 
In the slow freezing technique germplasm is gradually exposed to relatively low 
concentration of permeating cryoprotectants (CPs). These are usually glycerol or DMSO in 
the range of 1.0–1.5 M, which are added to the culture medium. Other cryoprotectants are 
widely used, alone or in various combinations. These include permeating CPs such as 
ethylene glycol (EG) and propylene glycol (e.g. Chen, 1986) and non-permeating ones 
such as sucrose, glucose, or fructose. The germplasm is then loaded in small volumes into 
straws and cooled to −7°C at −1 to −2°C/min, seeded at −7°C, and further cooled to −30°C 
to −35°C at −0.3°C/min, then free falling to −50°C before plunging into liquid nitrogen. 
This process often takes about 3 h. To date, there is no enough evidence to show that such 
slow cooling is necessary. 
Another important method to improve the survivial of cryopreserved oocytes is 
vitrification. The vitrification is an ultra rapid freezing method and requires three important 
factors: high cooling rate, high viscosity of the medium and small volume. (Arav, 1992, Arav 
et al., 2002). Cooling rate is achieved by directly putting sample into liquid nitrogen. The 
sample is plunged into liquid nitrogen resulting in cooling rates of hundreds to tens of 
thousands degrees Celsius per min, depending on the container, the volume, the thermal 
conductivity, the solution composition, etc.. For enhancing the cooling rate, liquid nitrogen 
slush is employed instead of liquid nitrogen. Nitrogen slush can be produced from liquid 
nitrogen by using vacuum. To achieve liquid nitrogen slush, the liquid nitrogen needs to be 
cooled close to its freezing point (-210 °C). Slush is generated by the VitMaster (IMT Ltd, 
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Ness Ziona, Israel), a device that reduces the temperature of the LN to between -205 and  
-210° C. Oocytes or embryos are suspended in the viscous medium. This is defined by the 
concentration and behavior of various CPs and other additives during vitrification. The 
higher the concentration of CPs, the higher the glass transition temperature (Tg), thus 
lowering the chance of ice nucleation and crystallization. Different CPs and other additives 
have different toxicity, penetration rate, and Tg. The combination of different CPs is often 
used to increase viscosity and Tg, and reduce the level of toxicity. In the cattle industry, to 
avoid handling of the post-warmed embryos and to allow direct embryo transfer, EG is 
often used as the permeating CP because of its high penetration rate (Saha et al., 1996).  
Recently, the less concentrated solution consisting of 15% (v/v) EG, 15% (v/v) DMSO or 
PROH and 0,5M sucrose with minimum volume can be used for human oocyte vitrification. 
This strategy further reduces solution toxicity. Another strategy to reduce toxic effects is the 
stepwise equilibration of cryoprotectants with 0.25 mL conventional straw. The cooling rate 
was around 2,500°C/minute and the warming rate was 1,300°C/minute. Using minimum 
volume method, a higher cooling rate can facilitate vitrification. Many techniques have been 
developed to reduce sample volume in the last decade. These techniques can generally be 
divided into two categories, surface technique and tubing technique. 
The surface techniques include EM grid, minimum drop size, MDS (Arav 1992; Arav & 
Zeron, 1997), Cryotop, Cryoloop, Hemi-straw, solid surface, nylon mesh, Cryoleaf, direct 
cover vitrification, fiber plug, vitrification spatula, Cryo-E, plastic blade, and Vitri-Inga. 
The tubing techniques include the plastic straw, OPS, closed pulled straw (CPS), flexipet-
denuding pipette, superfine OPS, CryoTip, pipette tip, high-security vitrification device, 
sealed pulled straw, Cryopette, Rapid-i and JY Straw. Each of these two groups has its 
specific advantages. In the surface methods, small drop (less 0.1ml) can achieve high 
cooling/warming rate because these systems are open. The tubing systems also may 
achieve high cooling rate in closed system and make samples untouched liquid nitrogen 
for safer and easier handle. Decreasing vitrified volume and increasing cooling rate allow 
a moderate decrease in CP concentration so as to minimize its toxic and osmotic 
hazardous effects (Barcelo-Fimbres & Seidel, 2007). The cryotop technique has been also 
modified by using a hermetically sealed container for storage to eliminate potential 
dangers of disease transmission. 
7.4 Ovarian tissue cryopreservation  
Another source of oocytes for gamete preservation is ovarian tissue removed for ovarian 
tissue cryopreservation. Large follicles 1 mm can easily be seen on the ovarian cortex and 
follicles greater than 5 mm may be aspirated to obtain immature cumulus-oocyte complexes. 
As the ovarian tissue is processed, smaller antral follicles rupture releasing oocytes that fall to 
the bottom of the dish ranging in size and quality from incompetent denuded oocytes to larger 
cumulus enclosed oocytes. Oocytes are collected from the bottom of every dish used and 
matured in vitro up to 40 h. By 24 h in culture the cumulus granulosa, surrounding the oocyte, 
begins to mucify resulting in cumulus cell differentiation and expansion. By 40 h, oocytes are 
stripped of cumulus cells and are examined for meiotic stage; the resulting MII oocytes are 
vitrified for potential future use. Although there are numerous reports about pregnancies with 
in vivo matured cryopreserved oocytes, only a very few of pregnancies have been obtained 
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using vitrified in vitro matured oocytes and no pregnancies with slow freezing in vitro matured 
oocytes by ovarian tissue cryopreservation. As mentioned previously, the cortex of a normal 
ovary is filled with arrested, immature, primordial follicles and hundreds of primordial 
follicles in a 1 mm3 piece of tissue. Unlike freezing embryos and mature oocytes, the 
primordial follicles in cortical tissue contain small oocytes that easily survive after freezing 
process when the tissue is cut into small strips of 1–2 mm × 1–2 mm × 10 mm.  
The common ovarian tissue slow freezing protocol is as follows: after incubation in 1.5 M 
ethylene glycol and 0.1 M sucrose for 20–30 min, cryovials with ovarian tissue pieces are 
cooled to −7°C at −2°C/min, seeded, and further cooled to −40°C at −0.3°C/min, then free 
falling to −100°C before storage in liquid nitrogen. Vials are thawed in a 37°C water bath, 
and tissue pieces are washed through progressively lower concentrations of cryoprotectant 
media (1.5, 1.0, 0.5,0) Methylene glycol.  
Ovarian tissue transplant following tissue cryopreservation was first successfully completed 
in mouse and has since been successful in sheep and primates, whose ovaries more resemble 
those of humans. In the last few years, more than 30 cases have described the 
transplantation of cryopreserved or vitrified tissue to heterotopic sites such as the forearm, 
as well orthotopic sites such as the abdomen or back to the residual ovary. It was found, on 
average, that hormone ciclycity resumed within 3 and 5 months of the ovarian tissue 
transplant, which represents the time it takes for follicle recruitment and subsequent 
growth. Ovarian tissue transplantation has resulted in the birth of six children to date. As 
cortical tissue is isolated from the ovary, it can be cut into thin strips and cryopreserved as 
mentioned above; however, due to their increased oocyte size, primary and secondary 
follicles fail to survive the in situ freezing process. It is hypothesized that individual follicle 
isolation allows for better penetration of cryoprotectants, thus helping to stabilize physical 
connections between the follicle cells and the oocyte. Therefore, a portion of cortical tissue 
can be cut into smaller pieces (2 mm3) and treated with enzymes such as liberase or 
collagenase that will break down stromal tissue to aid in the release of small follicles, which 
then can be cryopreserved for later use. Successful slow rate cryopreservation of small 
secondary follicles has been shown in mice, as well as in non-human primates and humans. 
After thawing, individual follicles can be encapsulated into a 3D matrix such as alginate, a 
hydrogel made from seaweed, which supports free passage of amino acids and secreted 
hormones and also serves as a scaffold for follicular development. It has been shown that 
fresh isolated follicles from prepubescent mice are capable of follicle growth from 150 to 350 
μm within 8 days of culture in alginate. 
8. Conclusion 
The widespread introduction of assisted reproductive technology over the past 20 years has 
seen a simultaneous increase in the development and utilization of cryopreservation 
technology. Cryopreservation is now considered an essential adjunction to modern 
reproductive treatments. It is now possible cryopreserve both gametes and embryos at a 
variety of different maturational stage to offer patients a significant range of options to suit 
their individual fertility problem. In addition to an improvement of modalities for the 
treatment of human infertility, the progress in cryopreservation of reproductive cells and 
tissues is enabling better management of livestock and laboratory animal species and better 
conservation of biodiversity. 
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As with assisted reproduction in general, cryopreservation technology has led to the 
development of a number of moral and ethical issue surrounding its use. A number of these 
are unresolved and will continue to generate considerable debate. 
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